These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 26913566

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Underutilization of A2 ABO incompatible kidney transplantation.
    Redfield RR, Parsons RF, Rodriguez E, Mustafa M, Cassuto J, Vivek K, Noorchashm H, Naji A, Levine MH, Abt PL.
    Clin Transplant; 2012; 26(3):489-94. PubMed ID: 22032287
    [Abstract] [Full Text] [Related]

  • 3. Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidates.
    Martins PN, Mustian MN, MacLennan PA, Ortiz JA, Akoad M, Caicedo JC, Echeverri GJ, Gray SH, Lopez-Soler RI, Gunasekaran G, Kelly B, Mobley CM, Black SM, Esquivel C, Locke JE.
    Am J Transplant; 2018 Aug; 18(8):1947-1953. PubMed ID: 29509285
    [Abstract] [Full Text] [Related]

  • 4. Transplantation of ABO A2 kidneys into O recipients: do IgM anti-A1 titers matter?
    Tierney J, Shaffer D.
    Clin Transplant; 2015 Apr; 29(4):379-82. PubMed ID: 25659826
    [Abstract] [Full Text] [Related]

  • 5. Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database.
    Kluger MD, Guarrera JV, Olsen SK, Brown RS, Emond JC, Cherqui D.
    Transplantation; 2012 Sep 15; 94(5):526-31. PubMed ID: 22874840
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. First Report on the OPTN National Variance: Allocation of A2 /A2 B Deceased Donor Kidneys to Blood Group B Increases Minority Transplantation.
    Williams WW, Cherikh WS, Young CJ, Fan PY, Cheng Y, Distant DA, Bryan CF.
    Am J Transplant; 2015 Dec 15; 15(12):3134-42. PubMed ID: 26372745
    [Abstract] [Full Text] [Related]

  • 9. ABO incompatible kidney transplantation - an analysis of UNOS Registry data.
    Futagawa Y, Terasaki PI.
    Clin Transplant; 2006 Dec 15; 20(1):122-6. PubMed ID: 16556166
    [Abstract] [Full Text] [Related]

  • 10. Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients.
    Axelrod D, Segev DL, Xiao H, Schnitzler MA, Brennan DC, Dharnidharka VR, Orandi BJ, Naik AS, Randall H, Tuttle-Newhall JE, Lentine KL.
    Am J Transplant; 2016 May 15; 16(5):1465-73. PubMed ID: 26603690
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S, Hwang E, Park S, Park U, Kim H, Cho W.
    Exp Clin Transplant; 2014 Oct 15; 12(5):401-4. PubMed ID: 25299367
    [Abstract] [Full Text] [Related]

  • 12. A2 to B Kidney Transplantation in the Post-Kidney Allocation System Era: A 3-year Experience with Anti-A Titers, Outcomes, and Cost.
    Shaffer D, Feurer ID, Rega SA, Forbes RC.
    J Am Coll Surg; 2019 Apr 15; 228(4):635-641. PubMed ID: 30710615
    [Abstract] [Full Text] [Related]

  • 13. A2/A2B to B kidney transplantation outcomes: A single center 7-year experience.
    El Chediak A, Shawar S, Fallahzadeh MK, Forbes R, Schaefer HM, Feurer ID, Rega S, Triozzi JL, Shaffer D.
    Clin Transplant; 2024 Apr 15; 38(4):e15295. PubMed ID: 38545909
    [Abstract] [Full Text] [Related]

  • 14. Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: A single-center Japanese cohort study.
    Kakuta Y, Okumi M, Unagami K, Iizuka J, Takagi T, Ishida H, Tanabe K.
    Clin Transplant; 2019 Jun 15; 33(6):e13591. PubMed ID: 31077450
    [Abstract] [Full Text] [Related]

  • 15. Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program.
    de Klerk M, Kal-van Gestel JA, Haase-Kromwijk BJ, Claas FH, Weimar W, Living Donor Kidney Exchange Program.
    Clin Transpl; 2011 Jun 15; ():287-90. PubMed ID: 22755421
    [Abstract] [Full Text] [Related]

  • 16. Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients.
    Bryan CF, Winklhofer FT, Murillo D, Ross G, Nelson PW, Shield CF, Warady BA.
    Transplantation; 2005 Jul 15; 80(1):75-80. PubMed ID: 16003236
    [Abstract] [Full Text] [Related]

  • 17. Current experience with renal transplantation across the ABO barrier.
    Nelson PW, Helling TS, Shield CF, Beck M, Bryan CF.
    Am J Surg; 1992 Nov 15; 164(5):541-4; discussion 544-5. PubMed ID: 1443385
    [Abstract] [Full Text] [Related]

  • 18. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U, Breimer ME, Friman S, Mjörnstedt L, Mölne J, Olausson M, Rydberg L, Svalander CT, Bäckman L.
    Xenotransplantation; 2006 Mar 15; 13(2):154-9. PubMed ID: 16623811
    [Abstract] [Full Text] [Related]

  • 19. Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.
    Massie AB, Orandi BJ, Waldram MM, Luo X, Nguyen AQ, Montgomery RA, Lentine KL, Segev DL.
    Am J Kidney Dis; 2020 Nov 15; 76(5):616-623. PubMed ID: 32668318
    [Abstract] [Full Text] [Related]

  • 20. Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment.
    Okada M, Watarai Y, Iwasaki K, Murotani K, Futamura K, Yamamoto T, Hiramitsu T, Tsujita M, Goto N, Narumi S, Takeda A, Morozumi K, Uchida K, Kobayashi T.
    Clin Transplant; 2017 Oct 15; 31(10):. PubMed ID: 28792635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.